Cook Venous Valve System for Treatment of Chronic Venous Insufficiency

NCT ID: NCT05883943

Last Updated: 2025-05-20

Basic Information

• Recruitment Status: ACTIVE_NOT_RECRUITING
• Clinical Phase: NA
• Total Enrollment: 4 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2023-04-24
• Study Completion Date: 2028-09-30

Brief Summary

The purpose of this study is to learn about the safety, efficacy and utility of a medical device called the Cook® Venous Valve System. This device, percutaneously placed in the leg, is meant to help the blood flow correctly through the veins in the leg.

Conditions

Venous Insufficiency of Leg

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Cook® Venous Valve System

Group Type: EXPERIMENTAL

Cook® Venous Valve System

Intervention Type: DEVICE

The Cook® Venous Valve is a permanent prosthetic, bicuspid, one-way flow valve designed to be percutaneously implanted into the peripheral deep venous system. The Cook® Venous Valve Delivery System is used to percutaneously deliver the Cook® Venous Valve into the deep venous system.

Interventions

Cook® Venous Valve System

The Cook® Venous Valve is a permanent prosthetic, bicuspid, one-way flow valve designed to be percutaneously implanted into the peripheral deep venous system. The Cook® Venous Valve Delivery System is used to percutaneously deliver the Cook® Venous Valve into the deep venous system.

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• Documented symptomatic deep venous reflux in one limb
• Deep venous reflux in the region of interest

Exclusion Criteria

General:

• Age < 18 years
• BMI ≥ 40
• Cultural objections to porcine materials
• Unwillingness or inability to comply with the follow-up
• Unwillingness to provide study data for duration of study
• Simultaneous participation in another device or drug study
• Inability or refusal to give informed consent

Medical:

• Pregnant, or planning to become pregnant
• Diagnosis of terminal illness with life expectancy less than 12 months
• Complete symptom resolution with compliant compression therapy for three months
• Untreated superficial venous disease
• Medical interventions including any of the following: planned procedure of any leg, vascular intervention or major surgery within the last three months, implanted inferior vena cava filter
• Medical history of any of the following: anticoagulation treatment for pulmonary embolism (within the last six months or ongoing), insulin dependent diabetes, chronic obstructive pulmonary disease, renal dysfunction requiring dialysis, leg amputation, bleeding diathesis, untreated or unresolved systemic infection or local infection, active malignancy except non-melanoma skin cancer, other acute or chronic medical condition that may cause noncompliance with the protocol or confound the study results, documented history of significant untreated stenosis within the arterial system
• Positive coronavirus (COVID-19) test six days prior to implant procedure

Anatomical:

• Inability to clearly visualize target implantation site
• Tortuous target implantation site
• Inadequate inflow and/or outflow to the target region

Procedural:

• Inability to gain access to the access site vein
• Untreated focal or diffuse stenosis

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

MED Institute Inc.

INDUSTRY

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Angiosur S.A.S.

Antioquia, , Colombia

Clínica de La Costa S.A.S.

Barranquilla, , Colombia

Fundacion Oftalmologica De Santander

Santander, , Colombia

Countries

Colombia

Other Identifiers

21-4344

Identifier Type: -

Identifier Source: org_study_id